Regulation of endogenous melanocortin-4 receptor expression and signaling by glucocorticoids

Endocrinology

Volumn 147, Issue 12, 2006, Pages 5948-5955

  Sebag, Julien A ^a   Hinkle, Patricia M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; DEXAMETHASONE; GLUCOCORTICOID; MELANOCORTIN 4 RECEPTOR; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FOOD INTAKE; GENE SEQUENCE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; MICE; RECEPTOR, MELANOCORTIN, TYPE 4; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 33751549891     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0984     Document Type: Article

References (45)

1. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB 2005 Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123:493-505
2. Cone RD 1999 The central melanocortin system and energy homeostasis. Trends Endocrinol Metab 10:211-216
3. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S 2003 Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348:1085-1095
4. Ste Marie L, Miura GI, Marsh DJ, Yagaloff K, Palmiter RD 2000 A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 97:12339-12344
5. Korner J, Wissig S, Kim A, Conwell IM, Wardlaw SL 2003 Effects of agouti-related protein on metabolism and hypothalamic neuropeptide gene expression. J Neuroendocrinol 15:1116-1121
6. Small CJ, Kim MS, Stanley SA, Mitchell JR, Murphy K, Morgan DG, Ghatei MA, Bloom SR 2001 Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes 50:248-254
7. Baran K, Preston E, Wilks D, Cooney GJ, Kraegen EW, Sainsbury A 2002 Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. Diabetes 51:152-158
8. Lu XY, Barsh GS, Akil H, Watson SJ 2003 Interaction between α-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. J Neurosci 23:7863-7872
9. Van der Ploeg LH, Martin WJ, Howard AD, Nargund RP, Austin CP, Guan X, Drisko J, Cashen D, Sebhat I, Patchett AA, Figueroa DJ, DiLella AG, Connolly BM, Weinberg DH, Tan CP, Palyha OC, Pong SS, MacNeil T, Rosenblum C, Vongs A, Tang R, Yu H, Sailer AW, Fong TM, Huang C, Tota MR, Chang RS, Stearns R, Tamvakopoulos C, Christ G, Drazen DL, Spar BD, Nelson RJ, MacIntyre DE 2002 A role for the melanocortin 4 receptor in sexual function. Proc Natl Acad Sci USA 99:11381-11386
10. Muceniece R, Zvejniece L, Kirjanova O, Liepinsh E, Krigere L, Vilskersts R, Baumane L, Gordjusina V, Kalvinsh I, Wikberg JE, Dambrova M 2005 β-MSH inhibits brain inflammation via MC(3)/(4) receptors and impaired NF-κB signaling. J Neuroimmunol 169:13-19
11. Giuliani D, Mioni C, Altavilla D, Leone S, Bazzani C, Minutoli L, Bitto A, Cainazzo MM, Marini H, Zaffe D, Botticelli AR, Pizzala R, Savio M, Necchi D, Schioth HB, Bertolini A, Squadrito F, Guarini S 2006 Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produce neuroprotection in cerebral ischemia. Endocrinology 147:1126-1135
12. Chaki S, Hirota S, Funakoshi T, Suzuki Y, Suetake S, Okubo T, Ishii T, Nakazato A, Okuyama S 2003 Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl-)ethyl]-4-[4- (2-met hoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. J Pharmacol Exp Ther 304:818-826
13. Hsu R, Taylor JR, Newton SS, Alvaro JD, Haile C, Han G, Hruby VJ, Nestler EJ, Duman RS 2005 Blockade of melanocortin transmission inhibits cocaine reward. Eur J Neurosci 21:2233-2242
14. Navarro M, Cubero I, Chen AS, Chen HY, Knapp DJ, Breese GR, Marsh DJ, Thiele TE 2005 Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor. Alcohol Clin Exp Res 29:949-957
15. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD 1994 Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298-1308
16. Lee YS, Challis BG, Thompson DA, Yeo GS, Keogh JM, Madonna ME, Wraight V, Sims M, Vatin V, Meyre D, Shield J, Burren C, Ibrahim Z, Cheetham T, Swift P, Blackwood A, Hung CC, Wareham NJ, Froguel P, Millhauser GL, O'Rahilly S, Farooqi IS 2006 A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab 3:135-140
17. Biebermann H, Castaneda TR, van Landeghem F, von Deimling A, Escher F, Brabant G, Hebebrand J, Hinney A, Tschop MH, Gruters A, Krude H 2006 A role for β-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab 3:141-146
18. Harrold JA, Williams G 2006 Melanocortin-4 receptors, β-MSH and leptin: key elements in the satiety pathway. Peptides 27:365-371
19. Pritchard LE, Turnbull AV, White A 2002 Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J Endocrinol 172:411-421
20. Pritchard LE, Armstrong D, Davies N, Oliver RL, Schmitz CA, Brennand JC, Wilkinson GF, White A 2004 Agouti-related protein (83-132) is a competitive antagonist at the human melanocortin-4 receptor: no evidence for differential interactions with pro-opiomelanocortin-derived ligands. J Endocrinol 180:183-191
21. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG 2000 Central nervous system control of food intake. Nature 404:661-671
22. Chai B, Li JY, Zhang W, Newman E, Ammori J, Mulholland MW, Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase. Peptides, in press
23. Vongs A, Lynn NM, Rosenblum CI 2004 Activation of MAP kinase by MC4-R through PI3 kinase. Regul Pept 120:113-118
24. Sutton GM, Duos B, Patterson LM, Berthoud HR 2005 Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus. Endocrinology 146:3739-3747
25. Akana SF, Strack AM, Hanson ES, Horsley CJ, Milligan ED, Bhatnagar S, Dallman MF 1999 Interactions among chronic cold, corticosterone and puberty on energy intake and deposition. Stress 3:131-146
26. Akana SF, Strack AM, Hanson ES, Dallman MF 1994 Regulation of activity in the hypothalamo-pituitary-adrenal axis is integral to a larger hypothalamic system that determines caloric flow. Endocrinology 135:1125-1134
27. Dallman MF, Akana SF, Strack AM, Hanson ES, Sebastian RJ 1995 The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons. Ann NY Acad Sci 771:730-742
28. Bruce BK, King BM, Phelps GR, Veitia MC 1982 Effects of adrenalectomy and corticosterone administration on hypothalamic obesity in rats. Am J Physiol 243:E152-E157
29. Green PK, Wilkinson CW, Woods SC 1992 Intraventricular corticosterone increases the rate of body weight gain in underweight adrenalectomized rats. Endocrinology 130:269-275
30. Tataranni PA, Larson DE, Snitker S, Young JB, Flatt JP, Ravussin E 1996 Effects of glucocorticoids on energy metabolism and food intake in humans. Am J Physiol 271:E317-E325
31. Axelrod J, Reisine TD 1984 Stress hormones: their interaction and regulation. Science 224:452-459
32. Chaki S, Ogawa S, Toda Y, Funakoshi T, Okuyama S 2003 Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents. Eur J Pharmacol 474:95-101
33. Vergoni AV, Bertolini A, Wikberg JE, Schioth HB 1999 Selective melanocortin MC4 receptor blockage reduces immobilization stress-induced anorexia in rats. Eur J Pharmacol 369:11-15
34. Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, Weiner RI 1990 Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 5:1-10
35. Khong K, Kurtz SE, Sykes RL, Cone RD 2001 Expression of functional melanocortin-4 receptor in the hypothalamic GT1-1 cell line. Neuroendocrinology 74:193-201
36. Shinyama H, Masuzaki H, Fang H, Flier JS 2003 Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144:1301-1314
37. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
38. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M 2000 Multiple actions of steroid hormones - a focus on rapid, nongenomic effects. Pharmacol Rev 52:513-556
39. Lubrano-Berthelier C, Cavazos M, Le Stunff C, Haas K, Shapiro A, Zhang S, Bougneres P, Vaisse C 2003 The human MC4R promoter: characterization and role in obesity. Diabetes 52:2996-3000
40. Blondet A, Gout J, Durand P, Begeot M, Naville D 2005 Expression of the human melanocortin-4 receptor gene is controlled by several members of the Sp transcription factor family. J Mol Endocrinol 34:317-329
41. Solano JM, Jacobson L 1999 Glucocorticoids reverse leptin effects on food intake and body fat in mice without increasing NPY mRNA. Am J Physiol 277:E708-E716
42. Freedman MR, Horwitz BA, Stern JS 1986 Effect of adrenalectomy and glucocorticoid replacement on development of obesity. Am J Physiol 250:R595-R607
43. Zakrzewska KE, Cusin I, Stricker-Krongrad A, Boss O, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F 1999 Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat. Diabetes 48:365-370
44. Drazen DL, Wortman MD, Schwartz MW, Clegg DJ, van Dijk G, Woods SC, Seeley RJ 2003 Adrenalectomy alters the sensitivity of the central nervous system melanocortin system. Diabetes 52:2928-2934
45. Yamano Y, Yoshioka M, Toda Y, Oshida Y, Chaki S, Hamamoto K, Morishima I 2004 Regulation of CRF, POMC and MC4R gene expression after electrical foot shock stress in the rat amygdala and hypothalamus. J Vet Med Sci 66:1323-1327